These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21609631)

  • 21. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The host response in experimental corneal xenotransplantation.
    Larkin DF; Williams KA
    Eye (Lond); 1995; 9 ( Pt 2)():254-60. PubMed ID: 7556727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corneal grafts in the second eye.
    Khodadoust AA; Karnema Y
    Cornea; 1984; 3(1):17-20. PubMed ID: 6399229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New thoughts on the immunology of corneal transplantation.
    Streilein JW
    Eye (Lond); 2003 Nov; 17(8):943-8. PubMed ID: 14631401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anterior chamber-associated immune deviation promotes corneal allograft survival.
    Niederkorn JY; Mellon J
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2700-7. PubMed ID: 8977485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mouse model of allogeneic corneal endothelial cell transplantation.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Cornea; 2008 Jul; 27(6):699-705. PubMed ID: 18580263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunogenic privilege of corneal allografts.
    Niederkorn JY; Peeler JS; Ross J; Callanan D
    Reg Immunol; 1989; 2(2):117-24. PubMed ID: 2701814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conditions affecting enhanced corneal allograft survival by oral immunization.
    Ma D; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1835-46. PubMed ID: 9727406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Class II alloantigen induced on corneal endothelium. Role in corneal allograft rejection.
    Donnelly JJ; Orlin SE; Wei ZG; Raber IM; Rockey JH
    Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1315-20. PubMed ID: 2194989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative evaluation of the corneal endothelium in the mouse after grafting.
    Plskova J; Kuffova L; Filipec M; Holan V; Forrester JV
    Br J Ophthalmol; 2004 Sep; 88(9):1209-16. PubMed ID: 15317718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological studies on the cellular phenotype involved in corneal allograft rejection.
    Yang P; Gong X; Zhou H; Zhao M; Huang X; Xie C; Li F
    Chin Med J (Engl); 1999 Mar; 112(3):202-6. PubMed ID: 11593548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial downgrowth after descemet stripping automated endothelial keratoplasty.
    Prasher P; Muftuoglu O; Hsiao ML; Bowman RW; Hogan RN; Mootha VV
    Cornea; 2009 Jul; 28(6):708-11. PubMed ID: 19512895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABO antigen blood-group compatibility in corneal transplantation.
    Borderie VM; Lopez M; Vedie F; Laroche L
    Cornea; 1997 Jan; 16(1):1-6. PubMed ID: 8985625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilocarpine-associated allograft rejection in postkeratoplasty patients.
    Massry GG; Assil KK
    Cornea; 1995 Mar; 14(2):202-5. PubMed ID: 7743805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human corneal endothelial cell expansion for corneal endothelium transplantation: an overview.
    Peh GS; Beuerman RW; Colman A; Tan DT; Mehta JS
    Transplantation; 2011 Apr; 91(8):811-9. PubMed ID: 21358368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corneal Immunosuppressive Mechanisms, Anterior Chamber-Associated Immune Deviation (ACAID) and Their Role in Allograft Rejection.
    Treacy O; Fahy G; Ritter T; O'Flynn L
    Methods Mol Biol; 2016; 1371():205-14. PubMed ID: 26530803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph node removal enhances corneal graft survival in mice at high risk of rejection.
    Plsková J; Holán V; Filipec M; Forrester JV
    BMC Ophthalmol; 2004 Mar; 4():3. PubMed ID: 15038832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunology of corneal allograft rejection: HLA-DR antigens on human corneal cells.
    Young E; Stark WJ; Prendergast RA
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):571-4. PubMed ID: 3884541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Emphasizing the prevention and treatment of immune rejection after corneal transplantation].
    Shi WY; Xie LX
    Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):3-5. PubMed ID: 16638272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.